SKIN
The Beauty Health CompanyNASDAQConsumer DefensiveAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
1.89
P/S
0.38
EV/EBITDA
7.01
DCF Value
$-14.50
FCF Yield
31.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
65.3%
Operating Margin
-6.9%
Net Margin
-3.2%
ROE
-15.4%
ROA
-2.8%
ROIC
-4.7%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $82.4M | $-8.1M | $-0.06 |
| FY 2025 | $300.8M | $-9.5M | $-0.16 |
| Q3 2025 | $70.7M | $-11.0M | $-0.09 |
| Q2 2025 | $78.2M | $19.7M | $0.03 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Consumer Defensive
Industry
—
Country
US
Exchange
NASDAQ
Beta
1.24
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.